176 related articles for article (PubMed ID: 8259632)
21. [Carnitine deficiency and carnitine therapy in a patient with Rett syndrome].
Plöchl E; Sperl W; Wermuth B; Colombo JP
Klin Padiatr; 1996; 208(3):129-34. PubMed ID: 8676601
[TBL] [Abstract][Full Text] [Related]
22. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
[TBL] [Abstract][Full Text] [Related]
23. Primary systemic carnitine deficiency under successful therapy: clinical, biochemical, ultrahistochemical and renal clearance studies.
von Petrykowski W; Ketelsen UP; Schmidt-Sommerfield E; Penn D; Sawicka E; Struck E; Lehnert W; Haap K; Strassburg HM
Clin Neuropathol; 1985; 4(2):63-71. PubMed ID: 3995808
[TBL] [Abstract][Full Text] [Related]
24. Primary carnitine deficiency cardiomyopathy.
Wang SS; Rao J; Li YF; Zhang ZW; Zeng GH
Int J Cardiol; 2014 Jun; 174(1):171-3. PubMed ID: 24746540
[No Abstract] [Full Text] [Related]
25. [The "big heart" of carnitine].
Gesuete V; Ragni L; Picchio FM
G Ital Cardiol (Rome); 2010 Sep; 11(9):703-5. PubMed ID: 21348188
[TBL] [Abstract][Full Text] [Related]
26. Thirty-year follow-up of carnitine supplementation in two siblings with hypertrophic cardiomyopathy caused by primary systemic carnitine deficiency.
Kishimoto S; Suda K; Yoshimoto H; Teramachi Y; Nishino H; Koteda Y; Itoh S; Kudo Y; Iemura M; Matsuishi T
Int J Cardiol; 2012 Aug; 159(1):e14-5. PubMed ID: 22154200
[No Abstract] [Full Text] [Related]
27. Familial hypertrophic cardiomyopathy and muscle carnitine deficiency.
Bautista J; Rafel E; Martinez A; Sainz I; Herrera J; Segura L; Chinchon I
Muscle Nerve; 1990 Mar; 13(3):192-4. PubMed ID: 2320040
[TBL] [Abstract][Full Text] [Related]
28. [Systemic carnitine deficiency: its place in Reye's syndrome (author's transl)].
Chapoy P; Angelini C; Cederbaum S
Nouv Presse Med; 1981 Feb; 10(7):499-502. PubMed ID: 7232195
[TBL] [Abstract][Full Text] [Related]
29. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency.
Mayatepek E; Nezu J; Tamai I; Oku A; Katsura M; Shimane M; Tsuji A
Hum Mutat; 2000 Jan; 15(1):118. PubMed ID: 10612840
[TBL] [Abstract][Full Text] [Related]
30. SLC22A5 mutations in a patient with systemic primary carnitine deficiency: the first Korean case confirmed by biochemical and molecular investigation.
Yoon YA; Lee DH; Ki CS; Lee SY; Kim JW; Lee YW; Park HD
Ann Clin Lab Sci; 2012; 42(4):424-8. PubMed ID: 23090741
[TBL] [Abstract][Full Text] [Related]
31. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
Wang Y; Kelly MA; Cowan TM; Longo N
Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939
[TBL] [Abstract][Full Text] [Related]
32. Expanded newborn screening identifies maternal primary carnitine deficiency.
Schimmenti LA; Crombez EA; Schwahn BC; Heese BA; Wood TC; Schroer RJ; Bentler K; Cederbaum S; Sarafoglou K; McCann M; Rinaldo P; Matern D; di San Filippo CA; Pasquali M; Berry SA; Longo N
Mol Genet Metab; 2007 Apr; 90(4):441-5. PubMed ID: 17126586
[TBL] [Abstract][Full Text] [Related]
33. [A cause of dilated cardiomyopathy in a child: primary carnitine deficiency].
Baragou S; Pio M; Di Bernardo S; Ksontini TB; Dommange SJ; Bonafe L; Meijboom E; Sekarski N
Ann Cardiol Angeiol (Paris); 2014 Apr; 63(2):107-10. PubMed ID: 22260907
[TBL] [Abstract][Full Text] [Related]
34. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy.
Helton E; Darragh R; Francis P; Fricker FJ; Jue K; Koch G; Mair D; Pierpont ME; Prochazka JV; Linn LS; Winter SC
Pediatrics; 2000 Jun; 105(6):1260-70. PubMed ID: 10835067
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic difficulties in a case of primary systemic carnitine deficiency with idiopathic dilated cardiomyopathy.
Kinali M; Olpin SE; Clayton PT; Daubeney PE; Mercuri E; Manzur AY; Tein I; Leonard J; Muntoni F
Eur J Paediatr Neurol; 2004; 8(4):217-9. PubMed ID: 15261886
[TBL] [Abstract][Full Text] [Related]
36. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.
Lamhonwah AM; Olpin SE; Pollitt RJ; Vianey-Saban C; Divry P; Guffon N; Besley GT; Onizuka R; De Meirleir LJ; Cvitanovic-Sojat L; Baric I; Dionisi-Vici C; Fumic K; Maradin M; Tein I
Am J Med Genet; 2002 Aug; 111(3):271-84. PubMed ID: 12210323
[TBL] [Abstract][Full Text] [Related]
37. A retrospective epidemiological and etiological study of metabolic disorders in children with cardiomyopathies.
Wang SM; Hou JW; Lin JL
Acta Paediatr Taiwan; 2006; 47(2):83-7. PubMed ID: 16927633
[TBL] [Abstract][Full Text] [Related]
38. [Carnitine deficiency and carnitine therapy].
Künnert B
Z Gesamte Inn Med; 1988 Jan; 43(1):1-5. PubMed ID: 3281380
[TBL] [Abstract][Full Text] [Related]
39. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter.
Nezu J; Tamai I; Oku A; Ohashi R; Yabuuchi H; Hashimoto N; Nikaido H; Sai Y; Koizumi A; Shoji Y; Takada G; Matsuishi T; Yoshino M; Kato H; Ohura T; Tsujimoto G; Hayakawa J; Shimane M; Tsuji A
Nat Genet; 1999 Jan; 21(1):91-4. PubMed ID: 9916797
[TBL] [Abstract][Full Text] [Related]
40. [Carnitine deficiency in inborn errors of metabolism].
Sela BA; Lerman-Sagie T; Berkovitz M
Harefuah; 1997 Nov; 133(10):419-23, 504. PubMed ID: 9418309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
